Urologix Inc (ULGX.PK)

ULGX.PK on OTC Markets Group

0.12USD
18 Sep 2014
Price Change (% chg)

$-0.00 (-4.09%)
Prev Close
$0.12
Open
$0.12
Day's High
$0.12
Day's Low
$0.12
Volume
4,000
Avg. Vol
35,381
52-wk High
$0.35
52-wk Low
$0.07

ULGX.PK

Chart for ULGX.PK

About

Urologix, Inc. (Urologix) develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement also known as benign prostatic hyperplasia (BPH). These therapies use technology in the treatment of BPH, a disease that affects... (more)
No analyst recommendations are available for ULGX.PK.

Overall

Beta: 0.87
Market Cap (Mil.): $2.24
Shares Outstanding (Mil.): 21.33
Dividend: --
Yield (%): --

Financials

  ULGX.PK Industry Sector
P/E (TTM): -- 43.73 33.70
EPS (TTM): -0.25 -- --
ROI: -99.66 6.73 17.35
ROE: -- 10.92 18.21
Search Stocks

Competitors

  Price Change
Abbott Laboratories (ABT.N) $43.59 -0.10
Pfizer Inc. (PFE.N) $30.40 -0.18
Sanofi SA (SASY.PA) €88.76 +0.30
Merck & Co., Inc. (MRK.N) $60.49 +0.18
GlaxoSmithKline plc (GSK.L) 1,449.00p +12.50
Boston Scientific Corporation (BSX.N) $12.41 -0.01
Olympus Corp (7733.T) ¥4,000 +40.00
Actavis Inc (WATS.O) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks